| scholarly article | Q13442814 |
| P50 | author | John K. Olynyk | Q37830523 |
| Kevin Croft | Q56085649 | ||
| P2093 | author name string | Anita C G Chua | |
| Debbie Trinder | |||
| Ross M Graham | |||
| Janina E E Tirnitz-Parker | |||
| Eng K Gan | |||
| Roheeth D Delima | |||
| P2860 | cites work | A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis | Q24310146 |
| Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis | Q24324055 | ||
| Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis | Q24533580 | ||
| Hereditary hemochromatosis in the post-HFE era | Q24646056 | ||
| HFE gene knockout produces mouse model of hereditary hemochromatosis | Q28263309 | ||
| Iron-overload-related disease in HFE hereditary hemochromatosis | Q28264901 | ||
| Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver | Q28506594 | ||
| A population-based study of the clinical expression of the hemochromatosis gene | Q33872904 | ||
| Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis | Q33894300 | ||
| The importance of non-transferrin bound iron in disorders of iron metabolism | Q34094818 | ||
| Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment | Q34120394 | ||
| In silico QTL mapping of basal liver iron levels in inbred mouse strains | Q34661915 | ||
| Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations | Q36116795 | ||
| Pathology of hepatic iron overload | Q36325770 | ||
| Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis. | Q36481958 | ||
| Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe | Q36790028 | ||
| Pathophysiology of iron toxicity. | Q40610814 | ||
| Function of the hemochromatosis protein HFE: Lessons from animal models | Q42619912 | ||
| Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells | Q43005719 | ||
| Mitochondrial damage, cytotoxicity and apoptosis in iron-potentiated alcoholic liver fibrosis: amelioration by taurine | Q46043125 | ||
| Elevated F2-isoprostanes in thalassemic patients | Q46883302 | ||
| Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives | Q47360264 | ||
| Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. | Q50530429 | ||
| HFE genotype in patients with hemochromatosis and other liver diseases. | Q51562649 | ||
| Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. | Q54459192 | ||
| Enhanced γ-Glutamyl Transpeptidase Expression and Selective Loss of CuZn Superoxide Dismutase in Hepatic Iron Overload | Q54975586 | ||
| Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene | Q59512946 | ||
| Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis | Q61895889 | ||
| Liver gene expression during chronic dietary iron overload in rats | Q67660492 | ||
| Biochemical liver profile in hemochromatosis. A survey of 100 patients | Q70222548 | ||
| 1,N6-Ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine in liver DNA from humans and untreated rodents detected by immunoaffinity/32P-postlabelling | Q72112941 | ||
| Iron overload facilitates hepatic fibrosis in the rat alcohol/low-dose carbon tetrachloride model | Q72131178 | ||
| Formation of 1,N6-ethenoadenine and 3,N4-ethenocytosine by lipid peroxidation products and nucleic acid bases | Q72278048 | ||
| Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis | Q73187936 | ||
| Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis? | Q73572635 | ||
| An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry | Q74482358 | ||
| Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene | Q78028899 | ||
| Studies on intermediary iron metabolism. V. The measurement of non-haemoglobin tissue iron | Q78619747 | ||
| Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3 | Q80174432 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 585-593 | |
| P577 | publication date | 2012-06-11 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice | |
| P478 | volume | 56 |
| Q53663275 | A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice. |
| Q92285385 | Ablation of Hepatocyte Smad1, Smad5, and Smad8 Causes Severe Tissue Iron Loading and Liver Fibrosis in Mice |
| Q36774034 | Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury |
| Q37364099 | Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features |
| Q40333897 | Characterization of ferroptosis in murine models of hemochromatosis. |
| Q38840947 | Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes |
| Q28607792 | Dating Endometriotic Ovarian Cysts Based on the Content of Cyst Fluid and its Potential Clinical Implications |
| Q35972918 | Elevated serum transaminase activities were associated with increased serum levels of iron regulatory hormone hepcidin and hyperferritinemia risk |
| Q34506653 | Gene co-expression networks shed light into diseases of brain iron accumulation |
| Q28396243 | Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis |
| Q91654887 | Inherited iron overload disorders |
| Q91740203 | Iron-Induced Liver Injury: A Critical Reappraisal |
| Q33682055 | Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice. |
| Q46734844 | Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload |
| Q51331048 | Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes. |
| Q37127064 | Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases |
| Q37543492 | The Regulation of Iron Absorption and Homeostasis |
| Q35125539 | Variability of the transferrin receptor 2 gene in AMD. |
Search more.